[1]Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018, 68(6): 394-424.
[2]曾成,祁国萍,沈颖,等.基于生物信息学的结肠癌核心基因筛选及验证[J].江苏大学学报(医学版),2021, 31(4): 296-302.
[3]Mármol I, SánchezdeDiego C, Pradilla Dieste A, et al.Colorectal carcinoma: a general overview and future perspectives in colorectal cancer[J].Int J Mol Sci,2017, 18(1): 197.
[4]Araghi M, Soerjomataram I, Jenkins M, et al.Global trends in colorectal cancer mortality: projections to the year 2035[J].Int J Cancer, 2019, 144(12): 2992-3000.
[5]Givel AM, Kieffer Y, ScholerDahirel A, et al.miR200regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers[J].Nat Commun, 2018, 9(1): 1056.
[6]Su S, Chen J, Yao H, et al.CD10+GPR77+cancerassociated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness[J].Cell, 2018, 172(4): 841-856.e16.
[7]唐雨婷,乔佳琦,许文荣,等.外泌体在糖尿病及其并发症中的作用研究进展[J].江苏大学学报(医学版), 2020, 30(4): 298-301.
[8]Dai G, Yao X, Zhang Y, et al.Colorectal cancer cellderived exosomes containing miR10b regulate fibroblast cells via the PI3K/Akt pathway[J].Bull Cancer, 2018, 105(4): 336-349.
[9]Rai A, Greening DW, Chen M, et al.Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome[J]. Proteomics, 2019, 19(8): 1800148.
[10]Hasegawa K, Kuwata K, Yoshitake J, et al.Extracellular vesicles derived from inflamed murine colorectal tissue induce fibroblast proliferation via epidermal growth factor receptor[J].FEBS J, 2021, 288(6): 1906-1917.
[11]Inoue T, Hayashi Y, Tsujii Y, et al.Suppression of autophagy promotes fibroblast activation in p53deficient colorectal cancer cells[J]. Sci Rep, 2021, 11(1): 19524.
[12]Webber J, Steadman R, Mason MD, et al.Cancerexosomes trigger fibroblast to myofibroblast differentiation[J].Cancer Res, 2010, 70(23): 9621-9630.
[13]Hong BS, Cho JH, Kim H, et al.Colorectal cancer cellderived microvesicles are enriched in cell cyclerelated mRNAs that promote proliferation of endothelial cells[J].BMC Genomics, 2009, 10(1): 556.
[14]Soldevilla B, Rodríguez M, San Millán C, et al.Tumorderived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival[J].Hum Mol Genet, 2014, 23(2): 467-478.
[15]Kahlert C, Kalluri R.Exosomes in tumor microenvironment influence cancer progression and metastasis[J].J Mol Med (Berl), 2013, 91(4): 431-437.
[16]Yoshii S, Hayashi Y, Iijima H, et al.Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression[J].Cancer Sci, 2019, 110(8): 2396-2407.
[17]Noh GT, Kwon J, Kim J, et al.Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines[J].PLoS One, 2020, 15(11): e0242057.
[18]Lucchetti D, Calapà F, Palmieri V, et al.Differentiation affects the release of exosomes from colon cancer cells and their ability to modulate the behavior of recipient cells[J].Am J Pathol, 2017, 187(7): 1633-1647.
[19]Hu Y, Yan C, Mu L, et al.Fibroblastderived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer[J].PLoS One, 2015, 10(5): e0125625.
[20]Hu JL, Wang W, Lan XL, et al.CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelialmesenchymal transition in colorectal cancer[J].Mol Cancer, 2019, 18(1): 91.
[21]Zhang HW, Shi Y, Liu JB, et al.Cancerassociated fibroblastderived exosomal microRNA243p enhances colon cancer cell resistance to MTX by downregulating CDX2/HEPH axis[J].J Cell Mol Med, 2021, 25(8): 3699-3713.
[22]Chen X, Liu J, Zhang Q, et al.Exosomemediated transfer of miR935p from cancerassociated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3[J].J Exp Clin Cancer Res, 2020, 39(1): 65.
[23]Chen X, Liu Y, Zhang Q, et al.Exosomal miR5903p derived from cancerassociated fibroblasts confers radioresistance in colorectal cancer[J].Mol Ther Nucleic Acids, 2020, 24: 113-126.
[24]Ren J, Ding L, Zhang D, et al.Carcinomaassociated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19[J].Theranostics, 2018, 8(14): 3932-3948.
[25]Deng X, Ruan H, Zhang X, et al.Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells[J].Int J Cancer, 2020, 146(6): 1700-1716.
[26]Bhome R, Goh RW, Bullock MD, et al.Exosomal microRNAs derived from colorectal cancerassociated fibroblasts: role in driving cancer progression[J].Aging (Albany NY), 2017, 9(12): 2666-2694.
[27]Zhang Y, Wang S, Lai Q, et al.Cancerassociated fibroblastsderived exosomal miR175p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGFβ1 positive feedback loop[J].Cancer Lett, 2020, 491: 22-35.
[28]Yin H, Yu S, Xie Y, et al.Cancerassociated fibroblastsderived exosomes upregulate microRNA135b5p to promote colorectal cancer cell growth and angiogenesis by inhibiting thioredoxininteracting protein[J].Cell Signal, 2021, 84: 110029.
[29]Zhou L, Li J, Tang Y, et al.Exosomal LncRNA LINC00659 transferred from cancerassociated fibroblasts promotes colorectal cancer cell progression via miR3423p/ANXA2 axis[J].J Transl Med, 2021, 19(1): 8.
[30]Oszvald , Szvicsek Z, Pápai M, et al.Fibroblastderived extracellular vesicles induce colorectal cancer progression by transmitting amphiregulin[J].Front Cell Dev Biol, 2020, 8: 558.
[31]OgataKawata H, Izumiya M, Kurioka D, et al.Circulating exosomal microRNAs as biomarkers of colon cancer[J].PLoS One, 2014, 9(4): e92921.
[32]Bahnassy AA, Salem SE, ElSayed M, et al.MiRNAs as molecular biomarkers in stage Ⅱ egyptian colorectal cancer patients[J].Exp Mol Pathol, 2018, 105(3): 260-271.
[33]Herrera M, Llorens C, Rodríguez M, et al.Differential distribution and enrichment of noncoding RNAs in exosomes from normal andcancerassociated fibroblasts in colorectal cancer[J].Mol Cancer, 2018, 17(1): 114.
[34]Mathivanan S, Lim JW, Tauro BJ, et al.Proteomics analysis of A33 immunoaffinitypurified exosomes released from the human colon tumor cell line LIM1215 reveals a tissuespecific protein signature[J].Mol Cell Proteomics, 2010, 9(2): 197-208.
[35]Sun B, Zhou Y, Fang Y, et al.Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes[J].Int J Cancer, 2019, 145(6): 1648-1659.
[36]Ganig N, Baenke F, Thepkaysone ML, et al.Proteomic analyses of fibroblast and serumderived exosomes identify QSOX1 as a marker for noninvasive detection of colorectal cancer[J].Cancers(Basel), 2021, 13(6):1351.
[37]Huang YJ, Huang TH, Yadav VK, et al.Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating spherederived exosomal βcatenin/STAT3/miR1246 cargoes[J].Am J Cancer Res, 2020, 10(8): 2337-2354.
|